Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12612000123842
ACTRN12612000123842
Recruiting
未知

Changes in bone structure, lean mass, and glucose metabolism in people with stroke: a two year observation study

Florey Neuroscience Institutes0 sites45 target enrollmentJanuary 25, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAcute Strokebone structure and densityglucose metabolismStroke - IschaemicStroke - Haemorrhagic

Overview

Phase
未知
Intervention
Not specified
Conditions
Acute Stroke
Sponsor
Florey Neuroscience Institutes
Enrollment
45
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 25, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Florey Neuroscience Institutes

Eligibility Criteria

Inclusion Criteria

  • •The inclusion criteria are (1\) a diagnosis of hemispheric stroke , (2\) onset of stroke \<1 week, (3\) medically stable, (4\) unable to ambulate within the first week after stroke, (5\) able to understand simple verbal commands.

Exclusion Criteria

  • •(1\) brainstem or cerebellar stroke, (2\) previous stroke in addition to the current admission, (3\) known type 1 or type 2 diabetes (4\) neurological conditions other than stroke (e.g. Parkinson’s disease) (5\) significant musculoskeletal condition impacting on function (e.g. amputation, severe arthritis), (6\) current or recent use of bone resorption inhibitors

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Changes in bone and surrounding soft tissue structure, metabolism, and vascularisation in Patient with periprosthetic joint infection of the knee and hipT84.5Infection and inflammatory reaction due to internal joint prosthesis
DRKS00022515Charité Campus Mitte60
Recruiting
Not Applicable
Changes in bone mineral density and serum calcium levels after romosozumab treatmet in postmenopausal osteoporosis patients:About short-term results at 6 months
JPRN-jRCT1040190111Kobayakawa Tomonori60
Active, not recruiting
Phase 1
Changes in weight, body composition and metabolic parameters in HIV infected patients after switch from 2- to 3-drug treatment
EUCTR2020-000205-89-DKDepartment of Infectious Diseases, Hvidovre Hospital126
Active, not recruiting
Phase 1
Changes in weight, body composition and metabolic parameters in HIV infected patients after switched treatment
EUCTR2019-004999-19-DKDepartment of infectious diseases, Hvidovre Hospital95
Active, not recruiting
Phase 1
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.
EUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46